These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 31009392)
41. A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis. Kim SJ; Yoon DH; Jaccard A; Chng WJ; Lim ST; Hong H; Park Y; Chang KM; Maeda Y; Ishida F; Shin DY; Kim JS; Jeong SH; Yang DH; Jo JC; Lee GW; Choi CW; Lee WS; Chen TY; Kim K; Jung SH; Murayama T; Oki Y; Advani R; d'Amore F; Schmitz N; Suh C; Suzuki R; Kwong YL; Lin TY; Kim WS Lancet Oncol; 2016 Mar; 17(3):389-400. PubMed ID: 26873565 [TBL] [Abstract][Full Text] [Related]
42. A Phase II Study of Methotrexate, Etoposide, Dexamethasone and Pegaspargase Sandwiched with Radiotherapy in the Treatment of Newly Diagnosed, Stage IE to IIE Extranodal Natural-Killer/T-Cell Lymphoma, Nasal-Type. Xu PP; Xiong J; Cheng S; Zhao X; Wang CF; Cai G; Zhong HJ; Huang HY; Chen JY; Zhao WL EBioMedicine; 2017 Nov; 25():41-49. PubMed ID: 29056540 [TBL] [Abstract][Full Text] [Related]
43. Extranodal NK/T-cell lymphoma, nasal type: Clinical features, outcome, and prognostic factors in 101 cases. Su YJ; Wang PN; Chang H; Shih LY; Lin TL; Kuo MC; Chuang WY; Wu JH; Tang TC; Hung YS; Dunn P; Kao HW Eur J Haematol; 2018 Sep; 101(3):379-388. PubMed ID: 29908084 [TBL] [Abstract][Full Text] [Related]
44. [Extra-nodal NK/T-cell lymphoma, nasal-type, revealed by cutaneous and ocular involvement]. Marzouki-Zerouali A; Charbit L; Mitcov M; Violon F; Schmutz JL; Moawad S; Bursztejn AC Ann Dermatol Venereol; 2019 Oct; 146(10):626-633. PubMed ID: 31371036 [TBL] [Abstract][Full Text] [Related]
45. A New Prognostic Index for Extranodal Natural Killer/T-Cell Lymphoma:Incorporation of Serum β-2 Microglobulin to PINK. Kang S; Cho H; Kim S; Lee K; Kang EH; Park JS; Lee YS; Park CS; Go H; Huh J; Ryu JS; Lee SW; Kim SJ; Kim WS; Yoon SE; Ko YH; Suh C Cancer Res Treat; 2023 Jan; 55(1):314-324. PubMed ID: 35381163 [TBL] [Abstract][Full Text] [Related]
46. Fasting blood glucose is a novel prognostic indicator for extranodal natural killer/T-cell lymphoma, nasal type. Cai Q; Luo X; Liang Y; Rao H; Fang X; Jiang W; Lin T; Lin T; Huang H Br J Cancer; 2013 Feb; 108(2):380-6. PubMed ID: 23299534 [TBL] [Abstract][Full Text] [Related]
47. EGR1 as a potential marker of prognosis in extranodal NK/T-cell lymphoma. Lee JY; Kim JH; Bang H; Cho J; Ko YH; Kim SJ; Kim WS Sci Rep; 2021 May; 11(1):10342. PubMed ID: 33990633 [TBL] [Abstract][Full Text] [Related]
48. Midtreatment ¹⁸F-FDG PET/CT Scan for Early Response Assessment of SMILE Therapy in Natural Killer/T-Cell Lymphoma: A Prospective Study from a Single Center. Khong PL; Huang B; Lee EY; Chan WK; Kwong YL J Nucl Med; 2014 Jun; 55(6):911-6. PubMed ID: 24819420 [TBL] [Abstract][Full Text] [Related]
49. Laryngeal Extranodal Nasal-type Natural Killer/T-cell Lymphoma: A Clinicopathologic Study of 31 Cases in China. Xiang CX; Chen ZH; Zhao S; Gao LM; Tao Q; Zuo Z; Liu XY; Liu WP Am J Surg Pathol; 2019 Jul; 43(7):995-1004. PubMed ID: 31045893 [TBL] [Abstract][Full Text] [Related]
51. Prognostic value of 25-hydroxy vitamin D in extranodal NK/T cell lymphoma. Mao J; Yin H; Wang L; Wu JZ; Xia Y; Zhu HY; Fan L; Li JY; Liang JH; Xu W Ann Hematol; 2021 Feb; 100(2):445-453. PubMed ID: 33140135 [TBL] [Abstract][Full Text] [Related]
52. Prognostic value of prognostic nutritional index on extranodal natural killer/T-cell lymphoma patients: A multicenter propensity score matched analysis of 1022 cases in Huaihai Lymphoma Working Group. Shen Z; Zhang S; Chen X; Zhang Q; Jiao Y; Shi Y; Zhang H; Ye J; Wang L; Zhu T; Miao Y; Wang L; Cai G; Sang W Hematol Oncol; 2023 Aug; 41(3):380-388. PubMed ID: 36680513 [TBL] [Abstract][Full Text] [Related]
53. Lymphocyte/Monocyte Ratio is a Novel Predictor for Early Stage Extranodal Natural Killer/T-cell Lymphoma, Nasal Type. Wang QX; Li SH; Ji BY; Wang HY; Li YY; Feng LL; Chen K; Xia YF; Zhang YJ J Cancer; 2017; 8(6):1030-1037. PubMed ID: 28529616 [No Abstract] [Full Text] [Related]
54. New prognostic model for extranodal natural killer/T cell lymphoma, nasal type. Cai Q; Luo X; Zhang G; Huang H; Huang H; Lin T; Jiang W; Xia Z; Young KH Ann Hematol; 2014 Sep; 93(9):1541-9. PubMed ID: 24782120 [TBL] [Abstract][Full Text] [Related]
55. Prognostic value of tumor 18F-FDG uptake in patients with untreated extranodal natural killer/T-cell lymphomas of the head and neck. Suh C; Kang YK; Roh JL; Kim MR; Kim JS; Huh J; Lee JH; Jang YJ; Lee BJ J Nucl Med; 2008 Nov; 49(11):1783-9. PubMed ID: 18927319 [TBL] [Abstract][Full Text] [Related]
56. The serum CXCL13 level is associated with the Glasgow Prognostic Score in extranodal NK/T-cell lymphoma patients. Kim SJ; Ryu KJ; Hong M; Ko YH; Kim WS J Hematol Oncol; 2015 May; 8():49. PubMed ID: 25966773 [TBL] [Abstract][Full Text] [Related]
57. Causes of mortality in cases with extra nodal natural killer/T-cell lymphoma, nasal type: A cohort study. Mei M; Wang Y; Zhang M PLoS One; 2019; 14(4):e0214860. PubMed ID: 30995261 [TBL] [Abstract][Full Text] [Related]
58. Expression of TIM-3 and LAG-3 in extranodal NK/T cell lymphoma, nasal type. Feng Y; Zhong M; Liu Y; Wang L; Tang Y Histol Histopathol; 2018 Mar; 33(3):307-315. PubMed ID: 28901003 [TBL] [Abstract][Full Text] [Related]
59. Prognostic significance of Ki-67 antigen expression in extranodal natural killer/T-cell lymphoma, nasal type. Jiang L; Li P; Wang H; Liu J; Zhang X; Qiu H; Zhang B Med Oncol; 2014 Oct; 31(10):218. PubMed ID: 25204411 [TBL] [Abstract][Full Text] [Related]
60. The correlation of clinicopathological features and prognosis in extranodal natural killer/T cell lymphoma: a report of 42 cases in the early stage. Zeng L; Huang W; Cao Z; Zheng B; Liu X; Guo L; Feng X Ann Hematol; 2019 Jun; 98(6):1467-1476. PubMed ID: 30895352 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]